Modulation of p145c-kit function in cells of patients with acute myeloblastic leukemia.
The function of the steel factor receptor, p145c-kit, in patient-derived acute myeloblastic leukemia (AML) cells was investigated. Steel factor stimulation of AML cells coexpressing p145c-kit and the progenitor cell antigen CD34 resulted in complete receptor down-regulation, a marked decrease of CD34 antigen expression, and the induction of the granulocyte lineage antigen CD15. These changes in surface marker expression paralleled morphological differentiation to granulated blasts and promyelocytes. Interestingly, the same phenotype was achieved by IL-3 stimulation of AML cells. p145c-kit extracellular domain-specific antibodies had either blocking or enhancing effects on ligand binding, receptor phosphorylation and down-regulation, and induction of cell proliferation. Correlations of these phenomena with distinct effects of antibody stimulation on cell substrate phosphorylation provide clues for the dissection of the p145c-kit signal and the analysis of its relevance for AML.
Bühring
H J
HJ
Section for Transplantation Immunology and Immunohematology, University of Tübingen.
Herbst
R
R
Kostka
G
G
Bossenmaier
B
B
Bartke
I
I
Kropshofer
H
H
Kalbacher
H
H
Busch
F W
FW
Müller
C A
CA
Schlessinger
J
J
D000818:Animals; D000911:Antibodies, Monoclonal / Q000276:immunology; D002454:Cell Differentiation; D015536:Down-Regulation; D016298:Hematopoietic Cell Growth Factors / Q000502:physiology; D006801:Humans; D007377:Interleukin-3 / Q000494:pharmacology; D015470:Leukemia, Myeloid, Acute / Q000378:metabolism / Q000473:pathology*; D051379:Mice; D008807:Mice, Inbred BALB C; D008970:Molecular Weight; D011518:Proto-Oncogene Proteins / Q000032:analysis / Q000502:physiology*; D019009:Proto-Oncogene Proteins c-kit; D019089:Stem Cell Factor
D000911:Antibodies, Monoclonal; D016298:Hematopoietic Cell Growth Factors; D007377:Interleukin-3; D011518:Proto-Oncogene Proteins; D019089:Stem Cell Factor; D019009:Proto-Oncogene Proteins c-kit